Fr. 23.90

Nine Tenths

English · Paperback / Softback

Shipping usually within 3 to 5 weeks (title will be specially ordered)

Description

Read more










Augment phase technology was rare. The last appearance of anything resembling phase technology was fifteen years ago. I knew the date...

It was the date of the Doctor Dimension repo.

In a world full of "Augments"--humans who use technology to imbue themselves with superpowers of every sort--being an average man would seem a good way to keep out of trouble. Not so for repo man Gayle Harwood. It's his job to seize enhancements from Augments who fall behind on the payments for their high-tech advantages. And they rarely part with them easily.

Now an infamous job Gayle was a part of long ago has come back to haunt him. An incredibly powerful piece of tech that was supposed to have been turned over to the government is being used again. People are dying, and those in power are convinced Gayle knows something about it.

Unfortunately, they're right.

And unless Gayle can uncover the sinister secrets of the past and find whoever has hijacked the lost tech and stop them, no superpower in the world is going to be enough to save him...

About the author










Jeff Macfee is a writer whose work has appeared in Needle: A Magazine of Noir, Shotgun Honey, and the anthology Killing Malmon. He wastes time on Twitter at @jmacfee.

Product details

Authors Jeff Macfee
Publisher Jabberwocky Literary Agency, Inc.
 
Languages English
Product format Paperback / Softback
Released 31.05.2022
 
EAN 9781625675491
ISBN 978-1-62567-549-1
No. of pages 296
Dimensions 140 mm x 213 mm x 18 mm
Weight 340 g
Subject Fiction > Science fiction, fantasy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.